2014
DOI: 10.1007/s12975-014-0343-0
|View full text |Cite
|
Sign up to set email alerts
|

Brain Arteriovenous Malformation Modeling, Pathogenesis, and Novel Therapeutic Targets

Abstract: Patients harboring brain arteriovenous malformation (bAVM) are at life-threatening risk of rupture and intracranial hemorrhage (ICH). The pathogenesis of bAVM has not been completely understood. Current treatment options are invasive and ≈ 20% of patients are not offered interventional therapy because of excessive treatment risk. There are no specific medical therapies to treat bAVMs. The lack of validated animal models has been an obstacle for testing hypotheses of bAVM pathogenesis and testing new therapies.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
69
0
2

Year Published

2014
2014
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 65 publications
(72 citation statements)
references
References 157 publications
(203 reference statements)
1
69
0
2
Order By: Relevance
“…In contrast, the loss of both alleles of any HHT causative gene is embryonically lethal in mice [34, 35], and conditional (tissue/time-specific) homozygous deletion of Eng [32] or Alk1 [36, 37] results in striking vascular malformations resembling the AVMs found in HHT. This has also been demonstrated in our previous studies in modeling bAVM in mice [23, 3840]. AVM development in an HHT gene-deficient mouse model is influenced by mouse strains, which have various levels of plasma TGF-β1 [41].…”
Section: Discussionsupporting
confidence: 69%
“…In contrast, the loss of both alleles of any HHT causative gene is embryonically lethal in mice [34, 35], and conditional (tissue/time-specific) homozygous deletion of Eng [32] or Alk1 [36, 37] results in striking vascular malformations resembling the AVMs found in HHT. This has also been demonstrated in our previous studies in modeling bAVM in mice [23, 3840]. AVM development in an HHT gene-deficient mouse model is influenced by mouse strains, which have various levels of plasma TGF-β1 [41].…”
Section: Discussionsupporting
confidence: 69%
“…An AVM is a collection of arteries and veins that form without an intervening capillary bed (22). However, a DVA is usually a collection of radiating veins that converge on a large and centrally located draining vein (23).…”
Section: Discussionmentioning
confidence: 99%
“…Bevacizumab normalized cardiac output in HHT patients harboring liver AVMs,[7] and was effective in the treatment of severe epistaxis caused by hemorrhage from small mucosal AVMs (telangiectasias). [6] Based on this, a phase I study on the efficacy and safety of bevacizumab in brain AVM patients is about to start (NCT02314377). A common angiogenesis pathway may, thus, explain radiological similarities between these two pathologies.…”
Section: Discussionmentioning
confidence: 99%